RECURSION PHARMACEUTICALS IN's ticker is RXRX and the CUSIP is 75629V104. A total of 133 filers reported holding RECURSION PHARMACEUTICALS IN in Q2 2022. The put-call ratio across all filers is 0.76 and the average weighting 2.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $4,314,248 | +104.2% | 575,233 | +171.4% | 0.00% | – |
| Q1 2024 | $2,113,142 | -37.5% | 211,950 | -38.1% | 0.00% | -100.0% |
| Q4 2023 | $3,378,638 | +1141.8% | 342,661 | +863.5% | 0.00% | – |
| Q3 2023 | $272,065 | -65.5% | 35,564 | -66.3% | 0.00% | – |
| Q2 2023 | $788,100 | +24.4% | 105,502 | +11.1% | 0.00% | – |
| Q1 2023 | $633,457 | +203.3% | 94,971 | +250.5% | 0.00% | – |
| Q4 2022 | $208,887 | -43.1% | 27,093 | -21.5% | 0.00% | – |
| Q3 2022 | $367,000 | +89.2% | 34,524 | +44.8% | 0.00% | – |
| Q2 2022 | $194,000 | +94.0% | 23,843 | +70.7% | 0.00% | – |
| Q1 2022 | $100,000 | -67.6% | 13,967 | -22.7% | 0.00% | – |
| Q4 2021 | $309,000 | – | 18,065 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Data Collective IV GP, LLC | 5,941,120 | $45,806,035 | 48.11% |
| Kinnevik AB (publ) | 7,653,061 | $59,005,100 | 33.28% |
| MV Management XI, L.L.C. | 1,971,908 | $15,203,411 | 26.45% |
| MIC Capital Management UK LLP | 8,451,758 | $65,163,057 | 12.86% |
| ArchPoint Investors | 1,114,626 | $8,593,766 | 4.07% |
| HARVARD MANAGEMENT CO INC | 1,509,254 | $11,636,348 | 1.44% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 2,710,339 | $20,896,714 | 0.80% |
| Duquesne Family Office | 1,385,950 | $10,685,675 | 0.53% |
| ALLEN OPERATIONS LLC | 217,657 | $1,678,135 | 0.45% |
| Artal Group S.A. | 960,204 | $7,403 | 0.41% |